136 related articles for article (PubMed ID: 36400155)
1. Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).
Miller P; Patel SR; Skinner R; Dignan F; Richter A; Jeffery K; Khan A; Heath PT; Clark A; Orchard K; Snowden JA; de Silva TI
J Infect; 2023 Jan; 86(1):1-8. PubMed ID: 36400155
[TBL] [Abstract][Full Text] [Related]
2. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
3. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Conrad A; Beguin Y; Guenounou S; Le Bourgeois A; Ménard AL; Rialland F; Layal S; Mamez AC; Yakoub-Agha I; El Cheikh J
Bull Cancer; 2024 Feb; 111(2S):S40-S49. PubMed ID: 37479644
[TBL] [Abstract][Full Text] [Related]
5. VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.
Conrad A; Boccard M; Valour F; Alcazer V; Tovar Sanchez AT; Chidiac C; Laurent F; Vanhems P; Salles G; Brengel-Pesce K; Meunier B; Trouillet-Assant S; Ader F;
BMJ Open; 2019 Feb; 9(2):e026093. PubMed ID: 30772864
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Hilgendorf I; Freund M; Jilg W; Einsele H; Gea-Banacloche J; Greinix H; Halter J; Lawitschka A; Wolff D; Meisel R
Vaccine; 2011 Apr; 29(16):2825-33. PubMed ID: 21345379
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
Groeneweg L; Loeffen YGT; Versluys AB; Wolfs TFW
Vaccine; 2021 Jun; 39(25):3338-3345. PubMed ID: 33992440
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-preventable disease following allogeneic haematopoietic stem cell transplant in Western Australia.
Ryan AL; Kerr F; Gough H; Carter TL; Kotecha RS
J Paediatr Child Health; 2019 Mar; 55(3):343-348. PubMed ID: 30184291
[TBL] [Abstract][Full Text] [Related]
9. Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant.
Colton H; Greenfield DM; Snowden JA; Miller PDE; Morley NJ; Wright J; Darton TC; Evans CM; de Silva TI
Vaccine; 2021 Aug; 39(34):4778-4783. PubMed ID: 34294480
[TBL] [Abstract][Full Text] [Related]
10. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation.
Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R;
Br J Haematol; 2022 Jul; 198(1):24-45. PubMed ID: 37655707
[TBL] [Abstract][Full Text] [Related]
11. Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.
Lerchenfeldt SM; Cronin SM; Chandrasekar PH
Transpl Infect Dis; 2013 Dec; 15(6):634-8. PubMed ID: 23890163
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT).
Clark A; Thomas S; Hamblin A; Talley P; Kulasekararaj A; Grinfeld J; Speight B; Snape K; McVeigh TP; Snowden JA
Br J Haematol; 2023 Apr; 201(1):35-44. PubMed ID: 36786081
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Review of Revaccination Patterns in Pediatric Hematopoietic Stem Cell Transplantation Recipients.
Wohlschlaeger A; Levy E; Khan RN; Heimall J; Fisher BT; Metjian TA; Elgarten CW; Freedman JL
J Pediatr Hematol Oncol Nurs; 2023; 40(4):259-264. PubMed ID: 37069829
[No Abstract] [Full Text] [Related]
14. Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.
Olkinuora H; Käyhty H; Davidkin I; Roivainen M; Olander RM; Kantele JM; Siitonen S; Vettenranta K
Acta Paediatr; 2012 Aug; 101(8):e373-7. PubMed ID: 22537137
[TBL] [Abstract][Full Text] [Related]
15. Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination.
Konishi T; Sekiya N; Otsuka Y; Konuma R; Wada A; Adachi H; Kishida Y; Nagata A; Yamada Y; Noguchi Y; Marumo A; Mukae J; Inamoto K; Toya T; Igarashi A; Najima Y; Kobayashi T; Sakamaki H; Ohashi K; Doki N
Int J Hematol; 2021 Aug; 114(2):263-270. PubMed ID: 33846960
[TBL] [Abstract][Full Text] [Related]
16. Immunisation practices of paediatric oncology and shared care oncology consultants: a United Kingdom survey.
Bate J; Patel SR; Chisholm J; Heath PT;
Pediatr Blood Cancer; 2010 Jul; 54(7):941-6. PubMed ID: 20162684
[TBL] [Abstract][Full Text] [Related]
17. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
Moore AS; Shaw PJ; Hallahan AR; Carter TL; Kilo T; Nivison-Smith I; O'Brien TA; Tapp H; Teague L; Wilson SR; Tiedemann K
Med J Aust; 2009 Feb; 190(3):121-5. PubMed ID: 19203307
[TBL] [Abstract][Full Text] [Related]
18. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).
Cordonnier C; Einarsdottir S; Cesaro S; Di Blasi R; Mikulska M; Rieger C; de Lavallade H; Gallo G; Lehrnbecher T; Engelhard D; Ljungman P;
Lancet Infect Dis; 2019 Jun; 19(6):e200-e212. PubMed ID: 30744963
[TBL] [Abstract][Full Text] [Related]
20. Antibody Response against Vaccine Antigens in Children after TCRαβ-Depleted Haploidentical Stem Cell Transplantation: Is It Similar to That in Recipients with Fully Matched Donors?
Kondolot M; Yilmaz E; Erdog Sahin N; Ozcan A; Kaynar L; Unal E; Karakukcu M
Transplant Cell Ther; 2023 Feb; 29(2):128.e1-128.e9. PubMed ID: 36323399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
